3,4,5-Trihydroxybenzamide;hydrate | 958232-25-2

• 分子结构分类: 有机化合物 - 苯类化合物 - 酚类
• 英文名称: 3,4,5-Trihydroxybenzamide;hydrate
• 英文别名: 3,4,5-trihydroxybenzamide;hydrate
• CAS: 958232-25-2
• 化学式: C7H9NO5
• 分子量: 187.15
• InChiKey: CHCHWTNUXJUBNZ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -0.92
• 重原子数：
  13
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  105
• 氢给体数：
  5
• 氢受体数：
  5

文献信息

• PROCESS FOR STRAIGHTENING KERATIN FIBRES WITH A HEATING MEANS AND DENATURING AGENTS
  申请人：Philippe Michel

  公开号：US20100028280A1

  公开（公告）日：2010-02-04

  The invention relates to a process for straightening keratin fibres, comprising: (i) a step in which a straightening composition containing at least two denaturing agents is applied to the keratin fibres, (ii) a step in which the temperature of the keratin fibres is raised, using a heating means, to a temperature of between 110 and 250° C.

  该发明涉及一种直发角蛋白纤维的拉直过程，包括：(i)将至少两种变性剂含有的拉直组合物涂抹到角蛋白纤维上的步骤，(ii)使用加热装置将角蛋白纤维的温度升高至110至250°C的步骤。
• Method for straightening keratinous fibers using heating means and an aromatic compound
  申请人：L'Oreal

  公开号：US11044978B2

  公开（公告）日：2021-06-29

  The invention concerns a method for straightening keratinous fibers including: (i) a step of applying on the keratinous fibers a hair straightening composition containing at least one polyhydroxylated aromatic compound, (ii) a step of increasing the temperature of the keratinous fibers, using heating means, to a temperature ranging between 110 and 250° C.

  本发明涉及一种拉直角质纤维的方法，包括：(i) 在角质纤维上涂抹含有至少一种多羟基芳香族化合物的拉直头发组合物，(ii) 使用加热装置将角质纤维的温度提高到 110 至 250 摄氏度之间。
• Catechins for the treatment of fibrillogenesis in Alzheimer's disease, Parkinson's disease, systemic AA amyloidosis, and other amyloid disorders
  申请人：——

  公开号：US20020151506A1

  公开（公告）日：2002-10-17

  A method of treating an amyloid disease, or a disease characterized by alpha-synuclein or NAC fibrillogenesis, in a mammalian subject. The method includes administering to the mammal a therapeutically effective amount of a various disclosed catechins or green tea extract. A pharmaceutical composition comprising a therapeutically effective amount of a catechin and a pharmaceutically acceptable excipient. The therapeutic amount of the catechin or green tea extract is selected for efficacy in treating amyloid, alpha-synuclein or NAC fibrillogenesis in a mammalian subject.

  一种治疗哺乳动物淀粉样蛋白疾病或以α-突触核蛋白或NAC纤丝化为特征的疾病的方法。该方法包括向哺乳动物施用治疗有效量的各种已公开的儿茶素或绿茶提取物。一种药物组合物，包含治疗有效量的儿茶素和药学上可接受的赋形剂。所选儿茶素或绿茶提取物的治疗量用于治疗哺乳动物体内的淀粉样蛋白、α-突触核蛋白或NAC纤丝化。
• CATECHINS FOR THE TREATMENT OF FIBRILLOGENESIS IN ALZHEIMER'S DISEASE, PARKINSON'S DISEASE, SYSTEMIC AA AMYLOIDOSIS, AND OTHER AMYLOID DISORDERS
  申请人：Proteotech Inc.

  公开号：EP1372682A2

  公开（公告）日：2004-01-02
• EP1372682A4
  申请人：——

  公开号：EP1372682A4

  公开（公告）日：2005-10-19